Company Comparison
BioNTech vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | BioNTech | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Mainz that develops immunotherapies and vaccines, particularly | San Diego |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | — | $48M |
| Valuation | — | — |
What They Build
BioNTech
BioNTech SE ( bee-ON-tek; or bye-ON-tek short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
AI Therapeutics
No investors listed.
Sector Overlap
Both BioNTech and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.